Man Hu

Nanjing Manhua Biotechnology (MHB) is a high-tech biomedical company based in China that specializes in the research, development, and manufacturing of advanced medical solutions. The company operates across several key domains, including biomedical 3D printing for personalized orthopedic implants, smart medical equipment, and novel detoxification biotechnology for treating drug addiction. MHB gained significant international visibility during the COVID-19 pandemic as a major manufacturer of protective supplies, including masks and test kits, exported to over 50 countries. Additionally, the company provides personalized medical services such as 5G telemedicine and health management schemes. With nearly 20 years of experience in 3D printing and over 30 years in detoxification research, MHB integrates clinical application with high-tech manufacturing to address complex healthcare needs.